Observational study / 2015
Light and moderate jogging were linked to lower all-cause mortality, suggesting a U-shaped association with jogging dose.
In the Copenhagen City Heart Study, 1,098 healthy joggers and 3,950 healthy nonjoggers were prospectively followed up since 2001 to investigate the link between jogging dose and all-cause mortality. Compared with sedentary nonjoggers, 1 to 2.4 hours of jogging per week was linked to the lowest mortality (multivariable HR: 0.29; 95% CI: 0.11 to 0.80). Optimal frequency was 2 to 3 times weekly (HR: 0.32; 95% CI: 0.15 to 0.69) or ≤1 time weekly (HR: 0.29; 95% CI: 0.12 to 0.72), and optimal pace was slow (HR: 0.51) or average (HR: 0.38). The lowest mortality HR was in light joggers (HR: 0.22; 95% CI: 0.10 to 0.47), followed by moderate joggers (HR: 0.66; 95% CI: 0.32 to 1.38), while strenuous joggers had a mortality rate not statistically different from the sedentary group (HR: 1.97; 95% CI: 0.48 to 8.14).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 1,098 healthy joggers and 3,950 healthy nonjoggers followed since 2001
- What was measured
- All-cause mortality
THE PAPER
Dose of jogging and long-term mortality: the Copenhagen City Heart Study.
Schnohr P, O'Keefe JH, Marott JL, Lange P, Jensen GB. J Am Coll Cardiol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.